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Summary
The control of IL-10 production and mechanisms that
mediate synergy between IFN-g and TLR ligands are
not well understood. We report that IFN-g augments
induction of TNFa by TLR ligands, immune com-
plexes, and zymosan by suppressing IL-10 production
and thereby interrupting Stat3-mediated feedback in-
hibition. IFN-g altered TLR2-induced signal transduc-
tion by increasing GSK3 activity and suppressing
MAPK activation, leading to diminished IL-10 produc-
tion. Inhibition of GSK3 or ablation of the GSK3b
gene ameliorated TLR2-induced peritonitis and arthri-
tis. IFN-g suppressed the activity of CREB and AP-1,
transcription factors that induce IL-10 expression
and are regulated in part by MAPKs and GSK3. These
results yield insight into mechanisms by which IFN-g
regulates IL-10 production and TLR2-mediated inflam-
matory responses and identify inhibition of CREB and
AP-1 as part of the macrophage response to IFN-g.
GSK3 and CREB/AP-1 are key players in integrating
IFN-g and TLR2 responses in innate immunity and
inflammation.
Introduction
A key effector function of activated macrophages is the
production of inflammatory cytokines and chemokines.
Potent activators of inflammatory cytokine production
include microbial products, immune complexes, and
TNF. Macrophages respond to microbial products with
pattern recognition receptors (PRRs) that recognize
conserved molecules, termed pathogen-associated
molecular patterns or PAMPs, expressed by microbes.
The Toll-like receptor (TLR) family of PRRs is comprised
of at least 11 receptors that play a key role in mediating
inflammatory responses to microbial infections (Akira
and Takeda, 2004). Examples include TLR2 and TLR4
that mediate recognition of, respectively, bacterial lipo-
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5 These authors contributed equally to this work.peptides and lipopolysaccharide (LPS). TLRs have also
been implicated in regulating the transition from innate
to acquired immunity (Hoebe et al., 2004; Iwasaki and
Medzhitov, 2004). Although the strong inflammatory ac-
tivation of dendritic cells (DCs) and macrophages by
TLRs has been linked to the development of Th1 re-
sponses (Schnare et al., 2001), there is accumulating ev-
idence that activation of specific TLRs, such as TLR2,
can be less inflammatory and favor the development of
Th2 responses (Agrawal et al., 2003; Dillon et al., 2004;
Pulendran et al., 2001; Re and Strominger, 2001;
Redecke et al., 2004).
Excessive inflammatory cytokine production results in
tissue damage and toxicity that is harmful to the host.
Thus, strong inducers of inflammatory cytokines also
activate homeostatic mechanisms that serve to limit
cell activation, cytokine production, and tissue damage.
One key homeostatic mechanism is the induction of IL-
10, a potent anti-inflammatory cytokine that mediates
a feedback inhibition loop that limits inflammatory cyto-
kine production. IL-10 inhibits multiple macrophage and
DC effector functions and plays a critical role in limiting
tissue injury during infections and in preventing autoim-
munity by limiting the duration and intensity of immune
and inflammatory reactions (Moore et al., 2001). Immune
complexes and TLR2 and TLR4 ligands are potent in-
ducers of IL-10. IL-10 induced by these factors limits en-
dotoxin toxicity and mediates the paradoxical suppres-
sive effects of immune complexes (Berg et al., 1995;
Gerber and Mosser, 2001; Miles et al., 2005). Induction
of IL-10 by TLR2 is particularly biologically significant,
as TLR2-induced IL-10 promotes Th2 responses in
vivo (Agrawal et al., 2003; Dillon et al., 2004; Pulendran
et al., 2001; Redecke et al., 2004) and represents an im-
portant pathogenic mechanism by which microbes that
activate TLR2, such as Yersinia pestis, suppress host
immune responses (Netea et al., 2004; Sing et al.,
2002a, 2002b). The suppressive effects of IL-10 on mye-
loid cells are dependent upon the signal transducer and
activator of transcription Stat3 (Takeda et al., 1999).
Glycogen synthase kinases 3 (GSK3) a and b are ho-
mologous serine/threonine kinases involved in signal
transduction downstream of Wnt, receptor tyrosine ki-
nases, and G protein-coupled receptors (Frame and Co-
hen, 2001). GSK3 phosphorylates multiple substrates,
including Wnt signaling components and transcription
factors NFATc, Jun, CREB, Myc, and HSF-1 (Doble
and Woodgett, 2003). Phosphorylation by GSK3 results
in inhibition of many of its substrates. For example,
phosphorylation of Jun by GSK3 negatively regulates
Jun’s DNA binding capacity (Boyle et al., 1991). GSK3
regulates many cellular functions, including glycogen
metabolism, cell-cycle control, and proliferation, has
been implicated in the pathogenesis of diabetes and
Alzheimer’s disease, and is under active investigation
as a therapeutic target in these diseases (Cohen and
Goedert, 2004). In vivo, homozygous deletion of the
GSK3b gene led to embryonic lethality characterized
by extensive liver degeneration (Hoeflich et al., 2000).
GSK3 activity is regulated by serine phosphorylation,
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564Figure 1. IFN-g Abrogates a TLR2-Induced, IL-10-Stat3-Dependent Feedback Inhibition Loop
(A) Control human primary macrophages or macrophages activated with 100 U/ml of IFN-g were stimulated with 10 ng/ml of Pam3Cys for 6 hr.
Whole cell extracts were analyzed by immunoblotting with antibodies against tyrosine-phosphorylated Stat3 (pY-Stat3), followed by probing the
same filter with antibodies against Stat3. One representative experiment out of eight performed is shown.
(B) Control or IFN-g-activated human macrophages were treated with 10 ng/ml of Pam3Cys for the indicated periods. mRNA expression levels of
SOCS3 were assessed by quantitative real-time PCR and normalized relative to levels of GAPDH.
(C) THP-1 monocytic cells were transduced with lentiviral particles encoding control small interfering RNA (siRNA) or Stat3 siRNA. Left: whole-
cell extracts were analyzed for Stat3 and Stat1 protein levels by immunoblotting. Right: virally transduced cells were stimulated with 10 ng/ml of
Pam3Cys for 18 hr and TNFaprotein levels in the culture supernatants were quantitated by ELISA (mean6SD of three independent experiments).
(D) Control human macrophages were pretreated with anti-IL-6 or anti-IL-10 neutralizing antibody for 30 min prior to a 6 hr stimulation with
Pam3Cys. Cell extracts were assayed for both pY-Stat3 and total Stat3 levels by immunoblotting.
(E) Human primary macrophages were stimulated with 10 ng/ml of Pam3Cys for 18 hr in the presence of increasing concentrations of anti-IL-10
neutralizing antibody. The concentration of isotype-matched control antibody corresponded to the highest dose of anti-IL-10 antibody. Levels of
TNFa in culture supernatants were determined by ELISA.which suppresses kinase activity. GSK3 is phosphor-
ylated and inactivated by serine kinases including Akt
and thus is regulated by the PI3K-Akt pathway that is ac-
tivated by multiple immune receptors.
IFN-g is a potent macrophage activating factor that
promotes antigen presentation, microbial killing, and
cytokine production (Schroder et al., 2004). Many of
these activating functions can be explained on the basis
of IFN-g-induced expression of immune/inflammatory
genes. Less is understood about another key property
of IFN-g, its capacity to dramatically enhance macro-
phage responses to other inflammatory factors such
as TLR ligands, immune complexes, and TNFa. Investi-
gation of the synergistic activation of macrophages by
IFN-g and TLRs/TNF has focused on enhanced activa-
tion of proinflammatory pathways. For example, IFN-g
enhances LPS- and TNF-induced NF-kB activation and
increases TLR expression (Schroder et al., 2004). We
reasoned that suppression of TLR-induced homeostatic
responses and feedback inhibitory pathways would pro-
vide an additional mechanism by which IFN-g syner-
gizes with TLRs and, in this study, analyzed the effects
of IFN-g on TLR2-induced production of IL-10 and acti-
vation of Stat3. We found that IFN-g inhibits IL-10 pro-
duction by regulating the activity of GSK3 and MAPKs
downstream of TLR2, with a concomitant suppression
of CREB and AP-1 transcription factors that are required
for IL-10 production. Our results yield insight into mech-
anisms by which IFN-g regulates TLR-mediated inflam-
matory responses and identify GSK3 and AP-1 proteins
as key players in the integration of IFN-g and TLR re-
sponses in innate immunity and inflammation.Results
IFN-g Abrogates IL-10-Stat3-Mediated Feedback
Inhibition by Suppressing IL-10 Expression
TLR4 ligation induces indirect activation of Stat3 that is
mediated predominantly by autocrine IL-10 (Carl et al.,
2004). Feedback inhibition of inflammatory cytokine
production by autocrine IL-10 is well established (Moore
et al., 2001), but the role of Stat3 that is activated down-
stream of TLR ligation has not been defined. We had
previously shown that IFN-g partially suppresses Stat3
function in the absence of any effect on Stat3 tyrosine
phosphorylation (Herrero et al., 2003; Hu et al., 2005b)
and wished to investigate the effects of IFN-g on TLR-in-
duced Stat3 and its potential homeostatic functions. We
chose to study Stat3 activation downstream of TLR2 be-
cause of the reported suppressive effects of TLR2 that
would be consistent with Stat3 activation (Netea et al.,
2004; Sing et al., 2002b). Primary human macrophages
were stimulated with Pam3CysSer(Lys)4 (a triacylated
peptide that stimulates via TLR2, hereafter termed
Pam3Cys), and activation of Stat3 was measured.
TLR2 stimulation of control macrophages resulted in
phosphorylation of Stat3 that became apparent 3 hr af-
ter stimulation and was sustained for at least 6 hr
(Figure 1A and data not shown). Expression of the
Stat3 target gene suppressor of cytokine signaling 3
(SOCS3) was induced in parallel with Stat3 activation
(Figure 1B), indicating that Stat3 was activated suffi-
ciently to induce gene expression. To assess the func-
tional role of Stat3 in limiting TLR2-induced inflamma-
tory cytokine production, we used RNA interference
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565Figure 2. IFN-g Inhibits IL-10 Expression In Vitro and In Vivo
(A) Control or IFN-g-activated human macrophages were stimulated with 10 ng/ml of Pam3Cys for indicated periods of time, and levels of IL-10
and TNFa in culture supernatants were determined by ELISA.
(B) Top: IL-10 mRNA levels were assessed by real-time PCR. Bottom: basal IL-10 protein levels in culture supernatants, prior to Pam3Cys ad-
dition, are shown. Each line represents an individual experiment performed with an independent blood donor.
(C) 6 week old C57BL/6J mice were injected intraperitoneally with 4 mg of IFN-g followed by injection of 100 mg of Pam3Cys. 1.5 hr post Pam3Cys
injection, serum levels of IL-10 and TNFa were determined by ELISA (mean 6 SD of four mice in each treatment group). Data represent two
independent experiments.
(D) Control or IFN-g-activated human macrophages were stimulated with 10 ng/ml of LPS for indicated periods of time (left), increasing doses of
zymosan for 18 hr (middle), or 75 mg/ml of immune complexes (IC) for 18 hr (right). IL-10 levels in culture supernatants were determined by ELISA.(RNAi) to ‘‘knock down’’ Stat3 expression. Pam3Cys in-
duced higher amounts of TNFa in cells that expressed
low levels of Stat3 (Figure 1C). These results demon-
strate a role for Stat3 in feedback inhibition of TLR2-in-
duced cytokine production.
The delayed activation of Stat3 suggested that TLR2
activated Stat3 indirectly, via autocrine action of cyto-
kines induced by TLR2. Experiments using neutralizing
antibodies showed that TLR2 activation of Stat3 in con-
trol cells was predominantly dependent upon IL-10,
whereas endogenous IL-6 made a minimal contribution
to Stat3 activation (Figure 1D). To confirm the role of en-
dogenous IL-10 in suppressing TLR2-induced TNFa
production, we used anti-IL-10 neutralizing antibodies.
Blocking endogenous IL-10 resulted in a substantial en-
hancement of TNFa production (Figure 1E), consistent
with previous reports of the role of autocrine IL-10 in reg-
ulating TLR function (Berg et al., 1995). Taken together,
the results show that IL-10 and Stat3 mediate feedback
inhibition of TLR2-induced TNFa production. Compared
with TLR2, TLR4 induced higher levels of TNFa, with an
incremental increase in TNFa production when IL-10
was neutralized (Figure S1).
We investigated the effects of IFN-g on TLR2-induced
Stat3 activation. Surprisingly, TLR2-dependent induc-
tion of Stat3 tyrosine phosphorylation was abolished in
IFN-g-activated macrophages (Figure 1A, lane 4), as
was induction of SOCS3 expression (Figure 1B). These
experiments suggested that IFN-g suppressed either
the production of IL-10 or the ability of IL-10 to activate
Stat3. We then used ELISA to measure IL-10 levels in cul-ture supernatants of TLR2-stimulated control or IFN-g-
activated macrophages. As expected, TLR2 stimulation
induced the time-dependent production of substantial
amounts of IL-10 in control cultures (Figure 2A, top). In
striking contrast, TLR2 stimulation of IL-10 production
was strongly suppressed in IFN-g-activated macro-
phages (Figure 2A, top). Concomitant with diminished
IL-10 production, Pam3Cys induced dramatically higher
levels of TNFa in IFN-g-activated macrophages (Fig-
ure 2A, bottom). These results were highly reproducible
among 25 experiments using macrophages derived from
independent blood donors. In parallel with suppression
of IL-10 protein production, IFN-g strongly suppressed
TLR2-induced expression of IL-10 mRNA (Figure 2B,
top). Interestingly, IFN-g suppressed basal (pre-TLR2
stimulation) IL-10 mRNA expression (Figure 2B, top);
basal IL-10 mRNA expression was suppressed by an av-
erage of 80% in six independent experiments (p < 0.0001
by paired Student’s t test). Basal levels of IL-10 protein in
culture supernatants were also suppressed by IFN-g
(Figure 2B, bottom). In addition, IFN-g inhibited induc-
tion of IL-10 by Pam3Cys in vivo, with a concomitant in-
crease in TNFa production (Figure 2C), thus recapitulat-
ing the reciprocal regulation of TNFa and IL-10 by IFN-g
that was observed in cultured cells (Figure 2A). We
wished to test whether IFN-g suppressed induction of
IL-10 production by receptors other than TLR2. IFN-g ef-
fectively inhibited induction of IL-10 by repurified LPS,
zymosan, and immune complexes that activate, respec-
tively, TLR4, TLR2 and Dectin-1, and FcgRs (Akira and
Takeda, 2004; Ravetch and Bolland, 2001; Rogers
Immunity
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Control or IFN-g-activated human macrophages were stimulated with 100 ng/ml of Pam3Cys, and cell extracts and mRNA were prepared. (A–C)
Extracts were analyzed by immunoblotting (A and C) and EMSA with an NF-kB binding radiolabeled oligonucleotide (B) P = phosphorylated. (D)
mRNA levels of MKP-1 were determined by real-time PCR. (E) Cell extracts were analyzed for p-Akt (ser473) and Akt protein levels by immuno-
blotting. (F) Cell extracts were assayed for both p-GSK and total GSK3b levels by immunoblotting. (G) GSK3 kinase assays with cell extracts from
control and IFN-g-activated human macrophages were performed as described in Experimental Procedures. One experiment representative of
three is shown.et al., 2005) (Figure 2D). Taken together, the results dem-
onstrate that IFN-g abrogates IL-10-Stat3-mediated
feedback inhibition by inhibiting induction of IL-10 by
multiple receptors.
IFN-gSuppresses TLR2Activation ofMAPKs andAkt
and Increases GSK3 Activity
We reasoned that IFN-g may disrupt a TLR2-induced
signal that is required for IL-10 expression and thus in-
vestigated the effects of preactivating macrophages
with IFN-g on TLR2 signaling. TLR2 signaling results in
the downstream activation of NF-kB, MAPKs (ERKs,
JNKs, p38), and PI3K (reviewed in Akira and Takeda,
2004). MAPK and PI3K activation is required for induc-
tion of IL-10 production by TLRs (Foey et al., 1998; Ma
et al., 2001; Martin et al., 2003), and PI3K has been
shown to suppress TNFa production by a mechanism
that has not yet been clarified (Fukao and Koyasu,
2003). TLR2-induced activation of NF-kB, as assessed
by degradation of IkBa, was comparable in control and
IFN-g-activated macrophages, although resynthesis of
IkBa was diminished in IFN-g-activated macrophages
in some experiments (Figure 3A and data not shown).
Activation of nuclear NF-kB DNA binding activity was
comparable or slightly enhanced in IFN-g-activated rel-
ative to control macrophages (Figure 3B). These results
are consistent with a mostly preserved activation of NF-
kB and a dispensable role for NF-kB in driving IL-10 ex-
pression (Moore et al., 2001). Next, we investigated theeffects of IFN-g on Pam3Cys/TLR2 activation of MAPK
pathways. As expected, TLR2 activated ERKs, JNKs,
and p38 rapidly and transiently (10–60 min) in control
macrophages (Figure 3C). In contrast, activation of
ERKs, JNKs, and p38 was suppressed in IFNg-primed
cells (Figure 3C). We were surprised by this result, but
diminished TLR2-induced MAPK activation has been
consistently detected in over 15 independent experi-
ments and could not be explained by increased degra-
dation of TRAF6 in IFN-g-activated cells, as was previ-
ously described in RANK signaling (Takayanagi et al.,
2000) (data not shown). We obtained the following addi-
tional evidence to support the validity of this result: (1)
Pam3Cys induction of a MAPK-dependent gene, MAP
kinase phosphatase 1 (MKP-1) (Sun et al., 1993), was di-
minished in IFN-g-activated macrophages (Figure 3D),
consistent with diminished MAPK activation in IFN-g-
activated cells; (2) MAPK activation by LPS was readily
detected in IFN-g-activated cells (Hu et al., 2005a), con-
firming that we were able to detect MAPK signals and
demonstrating differences in MAPK activation by LPS
(which activates Trif-dependent in addition to MyD88-
dependent signaling pathways) and Pam3Cys in IFN-g-
activated macrophages. The residual p38 and JNK
activity in IFN-g-activated, Pam3Cys-stimulated macro-
phages (Figure 3C, lanes 5–8) was sufficient for the TNFa
production that was observed in Figure 2A as this
TNFa production was reduced by the p38 inhibitor
SB203580 and the JNK inhibitor SP600215 (Figure S2).
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567Figure 4. IFN-g Inhibition of TLR2-Induced IL-10 Production Is Dependent on GSK3
(A) Human macrophages treated with or without 100 U/ml of IFN-g and the GSK3 inhibitors LiCl (20 mM) and SB415286 (10 mM) were stimulated
with 10 ng/ml of Pam3Cys for 18 hr. Results are means 6 SD of five independent experiments.
(B) Human macrophages were pretreated with IFN-g and LiCl as in (A) prior to 10 ng/ml of Pam3Cys stimulation. IL-10 mRNA expression was
measured by real-time PCR.
(C) Human macrophages were pretreated with IFN-g and LiCl as in (A), stimulated with 100 ng/ml of Pam3Cys for 6 hr, and cell extracts were
subjected to immunoblotting.
(D) Primary human macrophages transfected with control or GSK3b-specific short interfering RNAs were treated with IFN-g and Pam3Cys as in
(A) and IL-10 was measured by ELISA.
(E) Bone marrow-derived murine macrophages were generated from chimeric C57BL/6 mice that had been reconstituted with wild-type or
gsk3b2/2 fetal liver cells. Cells were treated with IFN-g (100 U/ml) overnight, stimulated for 18 hr with Pam3Cys, and IL-10 protein concentrations
in culture supernatants were determined by ELISA. A representative experiment is shown; mean inhibition was 5-fold in control cells and 2-fold in
gsk3b2/2 cells (n = 4).Overall, the results show that IFN-g specifically sup-
pressed the rapid and transient activation of MAPKs
by Pam3Cys/TLR2.
Next, we assessed activation of the PI3K-Akt pathway
by analyzing the phosphorylation of Akt downstream of
PI3K. In control macrophages, Akt was phosphorylated
at baseline, and phosphorylation increased, as pre-
dicted (Arbibe et al., 2000), after stimulation with
Pam3Cys (Figure 3E). In contrast, basal phosphorylation
of Akt was diminished in IFN-g-activated macrophages,
and the induction of phosphorylation by TLR2 was sup-
pressed (Figure 3E). We then determined the role of the
PI3K-Akt pathway in regulation of IL-10 production in
our system. Inhibition of Akt suppressed IL-10 produc-
tion (Figure S3A), as did deficiency of PI3K subunit
p85a (Figure S3B). Thus, macrophage IL-10 production
was dependent on the PI3K-Akt pathway.
Akt regulates the activity of GSK3, which, in turn, reg-
ulates the function of the AP-1 and CREB transcription
factors important for IL-10 production (Boyle et al.,
1991; Bullock and Habener, 1998; Cross et al., 1995;
Fiol et al., 1994; Grimes and Jope, 2001). Therefore, we
investigated the regulation of GSK3 by IFN-g and
TLR2. Consistent with the basal activity of Akt (Fig-
ure 3E), GSK3a and GSK3b were phosphorylated at
baseline on the inactivating residues, serine-21 and ser-
ine-9, respectively, in control macrophages, and phos-phorylation increased transiently after treatment with
Pam3Cys (Figure 3F). IFN-g strongly suppressed basal
GSK3 serine phosphorylation and inhibited TLR2-in-
duced phosphorylation (Figure 3F). Since phosphoryla-
tion of serine-21 and serine-9 is inhibitory for GSK3 ac-
tivity, these results suggested that IFN-g treatment
increased GSK3 activity. Indeed, GSK3b kinase activity
was substantially higher in IFN-g-activated than in con-
trol macrophages (Figure 3G). Overall, the results indi-
cate that IFN-g treatment of macrophages suppressed
MAPK and PI3K-Akt signaling pathways downstream
of TLR2, with a concomitant increase in GSK3 activity.
IFN-g Inhibition of TLR2-Induced IL-10 Production Is
Partially Mediated by GSK3
We considered GSK3 as a good candidate regulator of
IL-10 production because GSK3 regulates the function
of the AP-1 and CREB transcription factors that are im-
portant for IL-10 production (Boyle et al., 1991; Bullock
and Habener, 1998; Cross et al., 1995; Fiol et al., 1994;
Grimes and Jope, 2001). Therefore, we investigated
the role of GSK3 in mediating the regulation of IL-10 pro-
duction by IFN-g and TLR2. Inhibition of GSK3 activity
with two different GSK3 inhibitors that work by different
mechanisms, LiCl (Stambolic et al., 1996) and SB415286
(Smith et al., 2001), reversed IFN-g-mediated suppres-
sion of IL-10 protein and mRNA production (Figures 4A
Immunity
568Figure 5. Inhibition or Deficiency of GSK3 In Vivo Attenuates TLR2-Dependent Arthritis and Peritonitis
(A) Collagen-antibody-induced arthritis was induced in 6 week old C57BL/6J mice as described in Experimental Procedures. 3 mM of LiCl was
present in the drinking water of the LiCl-treated group from day 2. In addition, LiCl was injected i.p. at the dose of 50 mmol/mouse daily beginning
on day 2. The data represent mean 6 SD of four mice in each of two independent experiments.
(B) 6 week old C57BL/6J mice were i.p. injected with 100 mg of Pam3Cys. Starting from the day of Pam3Cys injection, half of the injected mice
were fed LiCl-containing drinking water (3 mM), and LiCl was injected i.p. at the dose of 50 mmol/mouse daily. 2 days after Pam3Cys adminis-
tration, peritoneal cells were harvested and counted. The results are derived from three to six mice in each group and are representative of
two independent experiments. P value was calculated by unpaired Student’s t test.
(C) Peritonitis was induced as in (B) by i.p. injection of 100 mg of Pam3Cys per mouse. Left: peritonitis in 6 week old gsk3b
+/2 and wild-type lit-
termate control mice (n = 4 in each group). Right: peritonitis in hematopoietic chimeras reconstituted with gsk3b+/+, gsk3b+/2, or gsk3b2/2 fetal
liver cells (n = 3 in each group). P value was calculated by unpaired Student’s t test.and 4B), resulting in the recovery of TLR2-induced Stat3
activation (Figure 4C). Consistent with relatively low
basal GSK3 activity in human macrophages in our sys-
tem (Figures 3F and 3G), inhibition of GSK3 in control
macrophages resulted in modest superinduction of IL-
10 production that was not observed in all blood donors
(data not shown). To obtain additional evidence sup-
porting a role for GSK3 in negative regulation of IL-10
production in primary human macrophages, we used
RNA interference to knock down GSK3b expression
(Figure 4D). Inhibition of TLR2-induced IL-10 production
by IFN-g was strongly attenuated in macrophages ex-
pressing low levels of GSK3b (Figure 4D). In addition,
we examined the regulation of IL-10 production in mu-
rine macrophages deficient in GSK3b. Consistent with
basal GSK3 activity and its transient inactivation by
TLR2 (Martin et al., 2005), higher levels of IL-10 were pro-
duced by GSK3b-deficient cells when subsaturating
concentrations of Pam3Cys were used (Figure 4E, bars
2 and 8). Strong suppression of IL-10 production by
IFN-g was observed in control cells and was attenuated
in GSK3b-deficient cells (mean 5-fold suppression in
control cells versus 2-fold suppression in GSK3b-defi-
cient cells [n = 4]), further supporting a role for GSK3 in
mediating IFN-g suppression of IL-10 (Figure 4E). The
partial effect of GSK3b-deficiency suggests that IFN-g
also activates a GSK3b-independent mechanism of sup-
pression of IL-10 production, and this will be further ad-
dressed below. These results establish GSK3b as a neg-
ative regulator of IL-10 and demonstrate that GSK3b
mediates at least in part the inhibitory effects of IFN-g
on IL-10 production. The results suggest that levels of
IL-10 production are determined by the reciprocal regu-
lation of GSK3 by IFN-g and TLR2 that was observed in
Figure 3F.
Role of GSK3 in TLR2-Induced Peritonitis
and Arthritis
The key role of GSK3 in suppressing IL-10 production
and thereby modulating the balance of pro- and anti-in-flammatory cytokines led us to test the effects of inhib-
iting GSK3 on TLR2-induced inflammation in vivo in mu-
rine models of arthritis and peritonitis. Collagen
antibody-induced arthritis (CAIA) is an established
model of the effector phase of inflammatory arthritis
(Terato et al., 1992). In this model, TLR-dependent acti-
vation of inflammatory cytokine production is required
to induce arthritis in mice that also have been injected
with anti-collagen antibodies. Inhibition of GSK3
strongly suppressed TLR2-dependent arthritis, as as-
sessed by joint swelling (Figure 5A).
Inhibition of GSK3 activity in vivo significantly amelio-
rated Pam3Cys-induced peritonitis as evidenced by re-
duced inflammatory exudates (Figure 5B). We wished
to test the effects of GSK3 deficiency on inflammatory
responses in vivo. GSK3a-deficient mice are not avail-
able, and GSK3b deficiency is embryonal lethal, but an
in vivo phenotype was observed in heterozygous
gsk3b+/2 mice (Hoeflich et al., 2000). Therefore, we ex-
amined the effects of GSK3b haploinsufficiency on
TLR2-dependent peritonitis. Pam3Cys-induced inflam-
matory peritoneal exudates were significantly reduced
in gsk3b+/2 mice (Figure 5C). We then used an adoptive
transfer approach to determine whether the role of
GSK3b in peritonitis was dependent on GSK3b expres-
sion in bone marrow-derived cells. Irradiated control
C57BL/6 mice were reconstituted with fetal liver cells
derived from gsk3b+/+, gsk3b+/2, and gsk3b2/2 em-
bryos. Pam3Cys-induced peritonitis was significantly at-
tenuated in chimeric mice reconstituted with gsk3b+/2
or gsk3b2/2 hematopoietic cells (Figure 5C). These re-
sults indicate that GSK3b is an important regulator of in-
flammation in vivo and suggest that GSK3 is a potential
therapeutic target for inflammatory disorders.
IFN-g Suppresses Activation of CREB
CREB and AP-1 transcription factors are important me-
diators of IL-10 production (Agrawal et al., 2003; Dillon
et al., 2004; Martin et al., 2005; Platzer et al., 1999;
Wang et al., 2005) that are activated by MAPKs and
IFN-g Regulation of IL-10 Mediated by GSK3 and AP-1
569Figure 6. Role of MAPKs and CREB/AP-1 in
IL-10 Production and Suppression of CREB
by IFN-g
(A) Control human macrophages were stimu-
lated with Pam3Cys for 6 hr in the presence or
absence of the p38 inhibitor SB203580
(10 mM), JNK inhibitor SP600215 (10 mM),
and the MEK-ERK inhibitor PD98059
(20 mM). IL-10 levels in culture supernatants
were determined by ELISA.
(B) Primary human macrophages were trans-
fected with control or CREB-, c-Fos-, and c-
Jun-specific short interfering RNAs, stimu-
lated with Pam3Cys (10 ng/ml) for 18 hr, and
IL-10 in culture supernatants was measured
by ELISA. Results are presented as mean 6
SD of three independent experiments. Re-
sults obtained with two different control
siRNAs were comparable. siRNA-mediated
protein knockdown from one representative
experiment is shown. Asterisk, p < 0.05 by
paired Student’s t test.
(C) Primary human macrophages were
treated overnight with IFN-g (100 U/ml), stim-
ulated with Pam3Cys, and phosphorylation of
p38 and CREB (serine-133) was measured by
immunoblotting.
(D) RNA was extracted from human macro-
phages that had been treated with IFN-g
overnight and stimulated with 10 ng/ml of
Pam3Cys for 6 hr, and mRNA levels of the
CREB-dependent gene PAI-2 were measured
by qPCR and normalized relative to GAPDH.inhibited by GSK3 (Boyle et al., 1991; Bullock and Hab-
ener, 1998; Grimes and Jope, 2001; Shaulian and Karin,
2001). Since IFN-g inhibited MAPK activation and in-
creased GSK3 activity, we investigated the effects of
IFN-g on CREB and AP-1 proteins. First, we established
the role of MAPKs, CREB, and AP-1 in IL-10 production
in our system. Inhibition of p38, JNK, and to a lesser ex-
tent MEK-ERKs, diminished TLR2-induced IL-10 pro-
duction (Figure 6A). RNAi-mediated knockdown of
CREB, Fos, and Jun expression also resulted in dimin-
ished TLR2-induced IL-10 production (Figure 6B). These
results confirm that MAPKs and CREB/AP-1 proteins
regulate IL-10 production in our system, similar to their
roles in IL-10 production in cells stimulated with differ-
ent TLR ligands (Agrawal et al., 2003; Dillon et al.,
2004; Foey et al., 1998; Lucas et al., 2005; Ma et al.,
2001; Martin et al., 2005; Platzer et al., 1999; Wang
et al., 2005; Yi et al., 2002).
Recent work from M. Karin’s laboratory has demon-
strated that TLR activation of CREB by phosphorylation
of serine-133 is dependent on p38 (Park et al., 2005),
which we confirmed in our system by using the p38
inhibitor SB203508 (data not shown). Since IFN-g
inhibited TLR2 activation of p38, we investigated the ef-
fects of IFN-g on activation of CREB. IFN-g suppressed
TLR2-induced phosphorylation of CREB on serine-133,
concomitant with suppression of p38 activation
(Figure 6C). Inhibition of CREB activation by IFN-g sup-
pressed TLR2 activation of the CREB-dependent gene
plasminogen activator 2 (PAI-2) (Park et al., 2005)
(Figure 6D). Taken together, these results suggest that
IFN-g suppresses TLR2-induced IL-10 production in
part by suppressing p38-dependent activation of CREB.IFN-g and GSK3 Suppress AP-1 Expression
and Function
ERKs and JNK phosphorylate, respectively, Fos and Jun,
thereby activating their transcriptional function and also
increasing their expression (Shaulian and Karin, 2001).
We next investigated the effects of IFN-g on Fos and
Jun. Interestingly, IFN-g strongly suppressed basal and
TLR2-inducible expression of c-Fos mRNA (p < 0.005
from three separate experiments by paired Student’s t
test) (Figure 7A) in a manner that correlated with suppres-
sion of IL-10 expression (Figures 2A and 2B). IFN-g also
suppressed the expression and nuclear accumulation
of Jun, AP-1 DNA binding activity, and TLR2-induced ex-
pression of the well-established AP-1 target genes MMP-
3 (Hu et al., 1994) and MKP-1 (Figures 7B–7E and
Figure 3D). Thus, IFN-g inhibited AP-1 expression and
function in macrophages, and suppressed AP-1 activity
explains the diminished expression of genes regulated
directly or indirectly by AP-1, including IL-10, that was
observed in IFN-g-activated macrophages.
GSK3 was previously reported to downregulate Jun
DNA binding (Boyle et al., 1991), and we wished to ad-
dress the role of GSK3 in mediating the inhibitory effects
of IFN-g on AP-1 proteins. Inhibition of GSK3 reversed
IFN-g-mediated suppression of AP-1 DNA binding,
with concomitant re-expression of the AP-1 target
genes MMP-3 (Figures 7C and 7E) and MKP-1 (data
not shown). In addition, IFN-g no longer suppressed
AP-1 DNA binding in GSK3b-deficient macrophages
(Figure 7D). Consistent with this result and previous re-
ports (Boyle et al., 1991; de Groot et al., 1993; Nikolakaki
et al., 1993), GSK3 effectively suppressed expression
of an AP-1-driven reporter gene (Figure 7F). Taken
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(A) Control and IFN-g-activated human primary macrophages were stimulated with 10 ng/ml of Pam3Cys. c-Fos mRNA expression was deter-
mined by real-time PCR.
(B) c-Jun expression in nuclear extracts from human primary macrophages was assessed by immunoblotting.
(C) Nuclear extracts from human primary macrophages were subjected to EMSA with a radiolabeled AP-1 binding oligonucleotide. The same
extracts were analyzed by immunoblotting with Sp1 antibodies.
(D) Bone marrow-derived murine macrophages were generated from chimeric C57BL/6 mice that had been reconstituted with gsk3b+/+ or
gsk3b2/2 fetal liver cells. Cells were treated with IFN-g (100 U/ml) overnight, stimulated with Pam3Cys, and AP-1 DNA binding activity was mea-
sured by EMSA. The same extracts were analyzed by immunoblotting with GSK3 antibodies.
(E) MMP-3 mRNA expression in human macrophages was determined by real-time PCR.
(F) 293T cells were cotransfected in triplicate with an AP-1 reporter construct and GSK3b expression plasmids (CA, constitutive active; KD, ki-
nase dead). 24 hr post transfection, cells from each transfection were split and stimulated with DMSO control or 100 ng/ml of PMA for 4 hr, and
cell lysates were analyzed for luciferase activity. Results from a representative experiment out of three are shown.together, the results clearly establish a role for GSK3b in
mediating the inhibitory effects of IFN-g on AP-1 DNA
binding and downstream IL-10 expression.
Discussion
In this study, we have discovered that IFN-g suppresses
macrophage production of the anti-inflammatory cyto-
kine IL-10 by regulating the function of GSK3 and of
CREB/AP-1 transcription factors. IFN-g increased the
activity of GSK3, which we established as a negative
regulator of IL-10 production, and diminished the activ-
ity and expression of CREB and AP-1 proteins that are
positive regulators of IL-10 production (Agrawal et al.,
2003; Dillon et al., 2004; Martin et al., 2005; Platzer
et al., 1999; Wang et al., 2005) (Figure 8). Our results pro-
vide the first link between IFN-g and GSK3 and CREB/
AP-1, and yield insights into mechanisms of negative
regulation of IL-10 production by IFN-g. The role of
GSK3 in regulating cytokine production is physiologi-
cally significant, as inhibition or deletion of GSK3 atten-
uated inflammatory arthritis and peritonitis in vivo. The
results also reveal mechanisms by which IFN-g inhibits
gene expression and suggest that suppression of
CREB- and AP-1-dependent genes is part of the IFN-g
response of macrophages.
Our results support a model whereby IFN-g specifi-
cally inhibits TLR2-induced signaling via the MAPK
and PI3K-Akt pathways (Figure 8). The direct targets
that are inhibited by IFN-g remain to be identified, and
we will investigate the effects of IFN-g on proximal
TLR2-induced signaling events in future work. One sig-
nificant consequence of the inhibition of PI3K-Akt sig-
naling is the release of GSK3 from inhibition (Figure 8).Active GSK3 then suppresses AP-1 DNA binding, which
was previously shown to occur by GSK3-dependent
phosphorylation of Jun on threonine 239, serine 243,
and serine 249 in a region proximal to the DNA binding
domain (Boyle et al., 1991). GSK3 can also contribute
to inhibition of CREB (Bullock and Habener, 1998;
Grimes and Jope, 2001). We have provided biochemical,
pharmacological, and genetic evidence that GSK3 plays
a key role in mediating the suppression of IL-10
Figure 8. Model for Regulation of IL-10 Production by IFN-g and
GSK3
IFN-g inhibits TLR2-mediated activation of MAPK and PI3K-Akt sig-
naling pathways, resulting in diminished p38, JNK, and ERK activity,
and increased activity of GSK3. GSK3 suppresses AP-1 function by
suppressing DNA binding. Diminished MAPK activity results in de-
creased activation of CREB (by p38) and decreased transcriptional
activity and expression of Fos and Jun.
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tion of TLR2 signaling and GSK3 activity with IL-10 pro-
duction and provide mechanistic insight into the regula-
tion of IL-10 expression. The regulation of IL-10
production by GSK3 downstream of PI3K and Akt pro-
vides a mechanism for the previously described nega-
tive regulation of macrophage inflammatory cytokine
production by the PI3K pathway (Fang et al., 2004; Fu-
kao et al., 2002; Guha and Mackman, 2002).
A second consequence of IFN-g-mediated alteration
of TLR2 signaling is suppression of activation of the
p38, JNK, and ERK MAPKs (Figure 8) that play a key
role in induction of IL-10 expression (Foey et al., 1998;
Lucas et al., 2005; Ma et al., 2001; Yi et al., 2002). Be-
cause p38 is a major activator of CREB downstream of
TLRs (Park et al., 2005; X.H., unpublished data), sup-
pression of p38 activation results in diminished CREB
activity and IL-10 expression. Diminished p38 activity
will also impact on other p38-dependent transcription
factors important for IL-10 expression, such as Sp1
(Ma et al., 2001). JNK and ERK are major inducers of
the transcriptional activity and expression of, respec-
tively, Jun and Fos (Shaulian and Karin, 2001; Davis,
2000). Therefore, IFN-g suppression of JNK and ERK ac-
tivation leads to decreased activity and expression of
Jun and Fos and thus diminished production of IL-10
(Figure 8). MAPK-mediated phosphorylation of Jun
that regulates its transcriptional activity occurs on dif-
ferent sites (serines 63 and 73) than GSK3-dependent
phosphorylation of threonine 239 and serines 243 and
349 that regulates DNA binding. Thus, IFN-g suppressed
AP-1 by two mechanisms—diminished activation by
MAPKs and GSK3-dependent inhibition of DNA binding.
Because Fos is a negative regulator of IL-12 production
(Dillon et al., 2004, and references therein), it is possible
that IFN-g inhibition of Fos regulates IL-10 expression
indirectly, by increasing IL-12 production. Experiments
with IL-12 neutralizing antibodies excluded a role for
IL-12 in regulating IL-10 in our system, where relatively
low levels of IL-12 were expressed (X.H., unpublished
data). However, addition of high concentrations of exo-
genous IL-12 suppressed IL-10 production. The role of
IL-12 in regulating IL-10 production under experimental
conditions in which high levels of endogenous IL-12 are
produced will be explored in future work.
An interesting question is whether there is crosstalk
between GSK3 and MAPK pathways downstream of
TLR2 and the extent to which increased GSK3 activity
contributes to IFN-g suppression of MAPKs (Figure 8,
dotted line). Experiments using GSK3b-deficient cells
and cells in which GSK3b expression was knocked
down by RNAi showed a role for GSK3 in attenuating
JNK and ERK activation downstream of TLR2 (Figure
S4A and data not shown). IFN-g was able to suppress
MAPK activation independently of GSK3b, but residual
JNK and ERK activation was higher in IFN-g-treated
GSK3b-deficient cells than in IFN-g-treated control cells
(Figure S4A, lanes 6 and 12) and was comparable to
activation in non-IFN-g-treated control cells (lane 3).
Consistent with this result, inhibition of GSK3 in human
macrophages partially (but reproducibly) attenuated in-
hibition of MAPKs by IFN-g at the 60 min time point
(Figure S4B). These results support a relatively minor
role for GSK3b in IFN-g regulation of MAPKs and sug-gest that IFN-g inhibits TLR2 signaling upstream of
GSK3 and MAPKs. IFN-g regulation of MAPKs indepen-
dently of GSK3 provides a plausible explanation for the
incomplete reversal of IFN-g-mediated suppression of
IL-10 production in GSK3b-deficient cells, although we
have not excluded a role for GSK3a. Taken together,
our results support a model whereby IFN-g suppresses
IL-10 production by two mechanisms: (1) IFN-g-depen-
dent suppression of MAPKs (leading to diminished
CREB phosphorylation and AP-1 transcriptional activity)
and (2) IFN-g activation of GSK3 (leading to diminished
AP-1 DNA binding). There is some crosstalk between
these two mechanisms because GSK3 modulates
MAPK activation, but IFN-g can inhibit MAPK activation
independently of GSK3b.
Mechanisms by which IFN-g activates macrophages
have been intensively studied (Schroder et al., 2004).
The most straightforward and best understood involve
IFN-g activation of the expression of multiple genes en-
coding inflammatory factors and immune effector mole-
cules. In addition, IFN-g renders macrophages hyperre-
sponsive to other inflammatory stimuli and microbial
products, such as TNFa and TLR ligands (Adams and
Hamilton, 1984; Schroder et al., 2004). Our results high-
light that suppression of IL-10 production by IFN-g con-
tributes to its proinflammatory properties. Suppression
of IL-10 production interrupts an IL-10-mediated
Stat3-dependent feedback inhibition loop that is in-
duced by TLR ligands, with the resultant increased pro-
duction of inflammatory cytokines. While this manu-
script was under preparation, Michalek and colleagues
reported that TLR4 transiently inactivates GSK3, leading
to increased IL-10 production mediated by enhanced
activity of CREB, and that pharmacological inhibition
of GSK3 protects mice from endotoxin shock (Martin
et al., 2005). We have substantially extended these re-
sults by using a genetic approach to definitively estab-
lish a role for GSK3 in inflammatory responses in vivo
and by showing that GSK3 is also regulated by IFN-g.
GSK3 is regulated by several signaling pathways (in-
cluding PI3K-Akt), and GSK3 activity is regulated in op-
posing directions by TLRs (transient inactivation) and
IFN-g (increase in kinase activity). Modulation of GSK3
activity by IFN-g provides a mechanism by which IFN-
g alters cellular responses to other factors that regulate
GSK3. GSK3 is thus located at a nodal point that inte-
grates signals from IFN-g and PRRs to regulate the bal-
ance between macrophage pro- and anti-inflammatory
cytokine production. The results provide a mechanism
for synergy between IFN-g and TLR ligands in macro-
phage activation and identify GSK3 as an attractive ther-
apeutic target for inflammatory diseases.
IFN-g induces gene expression by activating the tran-
scription factor Stat1 that binds to gene promoters and
initiates a cascade of gene activation. Multiple IFN-g-in-
duced Stat1-dependent genes have been identified and
their immune and inflammatory functions characterized
(Schroder et al., 2004). In contrast, the identity and im-
mune function of genes whose expression is sup-
pressed by IFN-g are less well established. There is no
clear evidence that Stat1 can act directly as a transcrip-
tional repressor, and mechanisms by which IFN-g sup-
presses gene expression are not known. Our results
provide a mechanism by which IFN-g downregulates
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activation of CREB and the activity and expression of
Fos and Jun. This suppression results not only in down-
regulation of IL-10, but also of the CREB-dependent
PAI-2 gene and the AP-1-dependent MKP-1 and MMP-
3 genes. It is likely that IFN-g regulation of CREB and
AP-1-dependent genes contributes more broadly to
the IFN-g-activated macrophage phenotype, and this
notion will be tested in future work.
Experimental Procedures
Cell Culture and Mice
Peripheral blood mononuclear cells (PBMCs) were obtained from
whole blood from disease-free volunteers by density gradient centri-
fugation with Ficoll (Invitrogen, Carlsbad, CA). CD14+ monocytes
were purified from fresh PBMCs with anti-CD14 magnetic beads
(Miltenyi Biotec, Auburn, CA), as recommended by the manufac-
turer. Purity of monocytes was greater than 97% as verified by
FACS. Macrophages were derived by culturing monocytes in RPMI
1640 medium (Invitrogen) supplemented with 10% FBS (Hyclone,
Logan, UT) in the presence of 10 ng/ml of human macrophage col-
ony stimulating factor (M-CSF) (Peprotech, Rocky Hill, NJ). IFN-g-
activated macrophages were obtained by culturing monocytes
with M-CSF and 100 U/ml of IFN-g (Roche, Indianapolis, IN) for 24
hr, unless otherwise noted. THP-1 cells were maintained in RPMI
1640 medium supplemented with 10% FBS. Murine bone marrow-
derived macrophages were obtained as described (Hu et al., 2002)
and maintained in DMEM supplemented with 20% FBS and 10 ng/
ml of murine M-CSF (Peprotech). To generate hematopoietic chi-
meras, donor fetal livers were harvested from embryonic day 13.5
embryos of gsk3b+/23 gsk3b+/2matings, and 23 106 fetal liver cells
were injected intravenously into each of the irradiated recipients.
Recipient mice (6 week old C57/BL6 mice) were obtained from Jack-
son Laboratory (Bar Harbor, ME) and were lethally irradiated with
1100 rads (split dose of 2 3 550 rads) on the day of transplantation.
Chimeric mice were sacrificed 7 weeks post transplantation. The es-
tablishment of gsk3b2/2 chimeras was confirmed by the absence of
GSK3b protein expression in bone marrow-derived macrophages,
alveolar macrophages, and peritoneal cells (Figure 4E and data
not shown). The experiments with human and murine cells were
approved by, respectively, the Hospital for Special Surgery
Institutional Review Board and Institutional Animal Care and Use
Committee.
Reagents
Pam3Cys was purchased from EMC microcollections (Tuebingen,
Germany) and was used at 10 ng/ml unless otherwise noted. Zymo-
san particles were from Molecular Probes (Eugene, OR). LPS, LiCl,
SB415286, and the MAPK inhibitors SB203580, SP600215, and
PD98059 were from Sigma-Aldrich (Milwaukee, WI). The p38 inhibi-
tor SB203580 and the MEK-ERK inhibitor PD98059 were used as
previously described (Ahmed and Ivashkiv, 2000; Sengupta et al.,
1998) in which inhibition of kinase activity was monitored. Cell viabil-
ity was comparable in control cells and cells treated with kinase in-
hibitors, as assessed by cell counts and annexin V and propidium io-
dide staining. Immune complexes were made as described with
modifications (Nagarajan et al., 1995). Briefly, human IgG was mixed
with goat anti-human IgG F(ab0)2 fragments at a molar ratio of 1:2.
The mixture was incubated at 4ºC overnight, and insoluble compo-
nents were removed by centrifugation. The soluble materials were
used as immune complexes.
Enzyme-Linked Immunosorbent Assay
Enzyme-linked immunosorbent assays (ELISAs) were performed
with paired antibody sets, as recommended by the manufacturer
(BD Pharmingen, San Diego, CA).
Analysis of mRNA Levels
For real-time, quantitative PCR, DNA-free RNA was extracted with
an RNeasy Mini kit (Qiagen, Valencia, CA), and 1 mg of total RNA
was reverse transcribed with a First Strand cDNA Synthesis kit (Fer-mentas, Hanover, MD). Real-time PCR was performed in triplicate
with the iCycler iQ thermal cycler and detection system (Biorad, Her-
cules, CA) and the PCR Core Reagents kit (Applied Biosystems, Fos-
ter City, CA). Relative expression was normalized for levels of gly-
ceraldehyde-3-phosphate dehydrogenase (GAPDH). When reverse
transcriptase was omitted, threshold cycle number increased by at
least ten, signifying lack of genomic DNA contamination or nonspe-
cific amplification, and the generation of only the correct size ampli-
fication products was confirmed by agarose gel electrophoresis.
Immunoblotting and Electrophoretic Mobility Shift Assay
Whole cell extracts and nuclear extracts were obtained, and protein
levels quantitated by the Bradford assay (Biorad, Hercules, CA), as
previously described (Hu et al., 2002). For immunoblotting, 10 mg
of cell lysates were fractionated on 7.5% or 10% polyacrylamide
gels by SDS-PAGE, transferred to polyvinylidene fluoride mem-
branes (Millipore, Billerica, MA), incubated with specific antibodies,
and enhanced chemiluminescence was used for detection. For AP-1
and NF-kB DNA binding assays, 5 mg of nuclear extracts were incu-
bated for 15 min at room temperature with 0.5 ng of 32P-labeled dou-
ble stranded AP-1 or NF-kB binding oligonucleotide (Ivashkiv et al.,
1990) in the presence of 2 mg of poly-dI-dC (Pharmacia), and com-
plexes were resolved on nondenaturing 4.5% polyacrylamide gels.
RNA Interference
Prevalidated siRNAs and nontargeting control siRNAs were pur-
chased from Dharmacon (Lafayette, CO). siRNAs were transfected
into primary human macrophages with the Amaxa Nucleofector de-
vice set to program Y-001 with the Human Monocyte Nucleofector
kit (Amaxa, Cologne, Germany). For Stat3 RNA interference (RNAi)
in THP-1 cells, lentiviral particles containing the sequence 50-AGT
CAGGTTGCTGGTCAAA-30 that targeted Stat3 were generated as
described (Hu et al., 2005b). Lentiviral particles encoding interfering
RNA against red fluorescence protein DSRed2 were used as control
for Stat3 RNAi experiments. THP-1 cells were incubated overnight
with recombinant lentiviral particles at a ratio of 1:50 in the presence
of 4 mg/ml polybrene. The efficiency of transduction was evaluated
by flow cytometry and fluorescence microscopy to monitor eGFP
expression and was typically >90%.
Immunoprecipitation and GSK3 Kinase Assay
107 human macrophages were lysed in the lysis buffer as described
(Hu et al., 2002). Cell lysates were incubated with polyclonal anti-
GSK3b antibody (Santa Cruz Biotechnology, Santa Cruz, CA) for 4
hr and then incubated with protein A/G agarose beads (Santa Cruz
Biotechnology) for 1 hr at 4ºC. The immunoprecipitates were pel-
leted and washed three times with cold lysis buffer and twice with
cold kinase buffer (25 mM HEPES, 10 mM MgCl2, and 1 mM dithio-
threitol). The kinase reactions were performed at 30ºC for periods
as noted in figure legends in the presence of a GSK3 peptide sub-
strate (Upstate Biotechnology, Charlottesville, VA), 10 mM of ATP,
and 10 mCi of [g-32P]ATP. The reactions were terminated by adding
an equal volume of tricine sample buffer (Biorad). The mixture was
boiled and loaded onto 16.5% Tris-Tricine gels (Biorad).
Collagen-Antibody-Induced Arthritis
Arthritis was induced in 6 week old C57BL/6 mice by intraperitoneal
(i.p.) administration of 4 mg of Arthrogen-CIA arthritis inducing
monoclonal antibody cocktail (Chemicon International, Temecula,
CA) at day 0 followed by injection of 120 mg of Pam3Cys on day 2.
The severity of arthritis was monitored by measuring the thickness
of both wrist and ankle joints. Joint swelling was measured with
a dial type caliper (Bel-Art Products, Pequannock, NJ).
Transient Transfection and Luciferase Assay
293T cells were transfected in triplicate in 24-well plates with an AP-
1 reporter construct and an expression plasmid encoding GSK3b or
a control empty vector and an internal control plasmid encoding Re-
nilla luciferase by using Superfect reagents from Qiagen. The plas-
mid encoding constitutive active Gsk3b contained a Ser9/Ala mu-
tation, and the plasmid encoding kinase dead GSK3b contained
a Lys85/Ala mutation (Stambolic and Woodgett, 1994). Three
hours posttransfection, cells were replenished with fresh medium
and cultured overnight. On the next day, cells from the same
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573transfected well were divided, stimulated with phorbol myristate ac-
etate (PMA) or a DMSO control for 4 hr, and cell lysates were pre-
pared and analyzed for firefly and Renilla luciferase activity with
the Luciferase Reporter Assay System from Promega (Madison,
WI). Because PMA induced Renilla luciferase activity, results are
shown normalized relative to amounts of cell lysate. Comparable re-
sults were obtained when results were normalized relative to Renilla
luciferase activity in cells that did not receive PMA, which reflects
transfection efficiency prior to splitting cells and subsequent treat-
ment with DMSO or PMA. Three independent experiments were per-
formed with triplicate transfections in each experiment.
Supplemental Data
Supplemental Data include four figures and are available at http://
www.immunity.com/cgi/content/full/24/5/563/DC1/.
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